A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderate to Severe Plaque Psoriasis
A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderate to Severe Plaque Psoriasis
Active, not recruiting · NCT06506916 · Registry updated 2026-07-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderate to Severe Plaque Psoriasis | Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, arthritic joint disease, arthropathy, bone disorder, musculoskeletal system disorder, psoriasis, psoriatic arthritis, skin disorder, spondylitis, vertebral column disorder | Active, not recruiting | Phase 3 | 2026-07-17 | NCT06506916 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| UCB Biopharma SRL | 30 |
14 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ps0039 40072 | Freiburg im Breisgau | Germany | 1 |
| Ps0039 40287 | Frankfurt am Main | Germany | 1 |
| Ps0039 40347 | Lodz | Poland | 1 |
| Ps0039 40515 | Berlin | Germany | 1 |
| Ps0039 40625 | Lodz | Poland | 1 |
| Ps0039 40757 | Poznan | Poland | 1 |
| Ps0039 40761 | Warsaw | Poland | 1 |
| Ps0039 40773 | Wroclaw | Poland | 1 |
| Ps0039 50110 | Ann Arbor | United States | 1 |
| Ps0039 50140 | Birmingham | United States | 1 |
| Ps0039 50162 | Fountain Valley | United States | 1 |
| Ps0039 50283 | Tampa | United States | 1 |
| Ps0039 50491 | Pittsburgh | United States | 1 |
| Ps0039 50643 | Rochester | United States | 1 |